Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Emory University
NRG Oncology
Wake Forest University Health Sciences
Cancer Research UK
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center